Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.

Shan B, Schaaf C, Schmidt A, Lucia K, Buchfelder M, Losa M, Kuhlen D, Kreutzer J, Perone MJ, Arzt E, Stalla GK, Renner U.

J Endocrinol. 2012 Sep;214(3):389-98. Epub 2012 Jun 27.

2.

Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.

Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, Rachinger W, Stalla GK, Schilling T, Arzt E, Perone MJ, Renner U.

Endocr Relat Cancer. 2009 Dec;16(4):1339-50. doi: 10.1677/ERC-09-0129. Epub 2009 Sep 2.

3.

Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells.

Schaaf C, Shan B, Onofri C, Stalla GK, Arzt E, Schilling T, Perone MJ, Renner U.

Neuroendocrinology. 2010;91(2):200-10. doi: 10.1159/000287236. Epub 2010 Feb 17.

PMID:
20160430
4.

Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.

Bae MK, Kim SH, Jeong JW, Lee YM, Kim HS, Kim SR, Yun I, Bae SK, Kim KW.

Oncol Rep. 2006 Jun;15(6):1557-62.

PMID:
16685395
5.

RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells.

Shan B, Gerez J, Haedo M, Fuertes M, Theodoropoulou M, Buchfelder M, Losa M, Stalla GK, Arzt E, Renner U.

Endocr Relat Cancer. 2012 Jan 9;19(1):13-27. doi: 10.1530/ERC-11-0211. Print 2012 Feb.

6.

HCG up-regulates hypoxia inducible factor-1 alpha in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum.

van den Driesche S, Myers M, Gay E, Thong KJ, Duncan WC.

Mol Hum Reprod. 2008 Aug;14(8):455-64. doi: 10.1093/molehr/gan040. Epub 2008 Jun 30.

PMID:
18591213
7.

Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.

Xiao Z, Liu Q, Zhao B, Wu J, Lei T.

Oncol Rep. 2011 Dec;26(6):1457-64. doi: 10.3892/or.2011.1416. Epub 2011 Aug 5.

PMID:
21822544
8.

Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.

Puppo M, Battaglia F, Ottaviano C, Delfino S, Ribatti D, Varesio L, Bosco MC.

Mol Cancer Ther. 2008 Jul;7(7):1974-84. doi: 10.1158/1535-7163.MCT-07-2059.

9.

Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line.

Cosío G, Jeziorski MC, López-Barrera F, De La Escalera GM, Clapp C.

Lab Invest. 2003 Nov;83(11):1627-36.

PMID:
14615416
10.

Platelet-derived growth factor (PDGF) and PDGF receptor expression and function in folliculostellate pituitary cells.

Kowarik M, Onofri C, Colaco T, Stalla GK, Renner U.

Exp Clin Endocrinol Diabetes. 2010 Feb;118(2):113-20. doi: 10.1055/s-0029-1202832. Epub 2009 Apr 16.

PMID:
19373754
11.

Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.

Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, Yasuda K, Kanzaki H.

Hum Reprod. 2012 Feb;27(2):523-30. doi: 10.1093/humrep/der405. Epub 2011 Nov 28.

PMID:
22128293
12.

Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.

Paradziej-Łukowicz J, Skwarska A, Peszyńska-Sularz G, Brillowska-Dąbrowska A, Konopa J.

Cancer Biol Ther. 2011 Oct 1;12(7):586-97. Epub 2011 Oct 1.

PMID:
21775820
13.

Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.

Alqawi O, Moghaddas M, Singh G.

Prostate Cancer Prostatic Dis. 2006;9(2):126-35. Epub 2006 Jan 24.

PMID:
16432534
14.

Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro.

Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U.

Neuroendocrinology. 2001 Aug;74(2):95-105.

PMID:
11474217
15.

BMP action in the pituitary: its possible role in modulating somatostatin sensitivity in pituitary tumor cells.

Otsuka F, Tsukamoto N, Miyoshi T, Iwasaki Y, Makino H.

Mol Cell Endocrinol. 2012 Feb 26;349(2):105-10. doi: 10.1016/j.mce.2011.10.017. Epub 2011 Oct 25. Review.

PMID:
22056414
16.

HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy.

Kun Z, Yuling Y, Dongchun W, Bingbing X, Xiaoli L, Bin X.

Technol Cancer Res Treat. 2016 Dec;15(6):NP95-NP104. Epub 2015 Dec 8.

PMID:
26647409
17.

Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas.

Fowkes RC, Vlotides G.

Endocr Relat Cancer. 2012 Jan 9;19(1):C1-5. doi: 10.1530/ERC-11-0297. Print 2012 Feb.

18.

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia.

Park SY, Jang WJ, Yi EY, Jang JY, Jung Y, Jeong JW, Kim YJ.

J Pineal Res. 2010 Mar;48(2):178-84.

PMID:
20449875
19.

Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.

Pourgholami MH, Cai ZY, Badar S, Wangoo K, Poruchynsky MS, Morris DL.

BMC Cancer. 2010 Apr 15;10:143. doi: 10.1186/1471-2407-10-143.

20.

Supplemental Content

Support Center